Welcome to Our Research Archive
Search and filter by content type, issue area, author, and keyword
August 25, 2025
Trump vs Biden on Science Integrity
Since the George W. Bush administration and under both parties, the White House has focused on scientific integrity. However, Republicans and Democrats have conflicting views on what that means. For Democrats, scientific integrity centers on protecting government scientists and the science that they conduct from political interference from higher-ups. For Republicans — who under President Trump…
August 21, 2025
When Harry Became Sally | Interview: Carole Hooven
Carole Hooven, evolutionary biologist and nonresident fellow at the American Enterprise Institute, joins Jonah Goldberg to discuss the differences between gender and sex, homosexuality in the animal kingdom, and epigenetics.
July 29, 2025
The War on Science
An unparalleled group of prominent scholars from wide-ranging disciplines detail ongoing efforts to impose ideological restrictions on science and scholarship throughout western society. From assaults on merit-based hiring to the policing of language and replacing well-established, disciplinary scholarship by ideological mantras, current science and scholarship is under threat throughout western institutions. As this group of…
July 14, 2025
Precipitation Paradox?
There is a cynical trick being played by some climate activists to promote misinformation and undercut the assessments of the Intergovermental Panel on Climate Change (IPCC) as they lobby for changes in energy policy. The trick goes like this: At the core of this line of reasoning is the exploitation of an apparent paradox: How…
July 14, 2025
Do Women Owe Men an Apology? With Dr. Carole Hooven
This episode starts with a Very Special introduction in which I explain what’s been going on with the podcast over the last six months (lots of different offerings, which possibly caused some confusion) and talk about the ongoing challenges of the subscriber model. (Short version, please stick around!) I then have the great pleasure of…
June 25, 2025
So You Want to Go Pro?
Ten years ago today I published a post at my sport governance blog, The Least Thing, that explored who had a greater chance of “going pro” — the men’s NCAA Division 1 basketball player or the PhD graduate seeking a tenure track job in a university? At the time it was a fun exploration of an…
June 16, 2025
“The Global Fertility Crisis is Worse Than You Think”
The title of today’s post comes from an excellent recent talk in London given by my AEI colleague (and University of Pennsylvania professor), Jesús Fernández-Villaverde. Today I look at the simple math of population projections to clarify the nature of the “crisis” — which is indeed worse than I thought. On X/Twitter, JFV summarized his talk as follows: The…
June 4, 2025
What is a “Worst Case” Climate Scenario?
The implausibly extreme and hugely popular climate scenario RCP8.5 made it into President Trump’s executive order last week on “Restoring Gold Standard Science.” Ironically, the Trump administration’s characterization of RCP8.5 did not quite reach the “gold standard,” and maybe not even a “bronze standard. “ The EO states: [Federal a]gencies have used Representative Concentration Pathway…
June 3, 2025
The Politicization of Intelligence, Part 2
In Part 1 of this two-part series I discussed the National Intelligence Council (NIC) and its role iin synthesizing and summarizing intelligence from across the U.S. government’s intelligence gathering agencies. Today, in Part 2 I take a broader look at the challenges of securing reliable intelligence in an environment characterized by ever-present politics. Intelligence in decision making “includes…
May 30, 2025
A Bitter Pill to Swallow: American Drug Shortages
While drug pricing has been a consistent focus for policymakers concerned about access to medicine, another significant barrier to care has grown: drug shortages. Drug shortages have become more prevalent, with causes ranging from problems at manufacturing facilities, compliance with regulation to unpredictable demand. An insufficiently profitable market, particularly for complex generic medicines, discourages investment…